Compare Summit Therapeutics Inc (SMMT) vs Uber Technologies Inc (UBER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Uber Technologies Inc — how do they compare? Summit Therapeutics Inc trades at $15.56 (market cap $12.06B), while Uber Technologies Inc trades at $77.78 (market cap $160.42B). The key difference: Uber Technologies Inc is far larger — about 13.3× Summit Therapeutics Inc's market cap, and Uber Technologies Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | UBER | |
|---|---|---|
Market Cap | $12.06B | $160.42B |
Sector | Health | Industrials |
52-Week High | $26.98 | $100.10 |
52-Week Low | $12.55 | $65.94 |
Enterprise Value | $11.39B | $169.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Uber (UBER) trades at $78.03, up 4.01% today, with strong bullish technical signals and robust fundamentals including 2025 revenue of $52.02B and net income of $10.05B. Recent news highlights expansion in autonomous vehicle partnerships, such as the robotaxi pilot in Madrid with WeRide, while the company streamlines operations with HR layoffs and implements AI spending caps to manage costs.
The outlook remains positive with a consensus price target of $102.88, representing significant upside, driven by earnings beats and strategic initiatives in autonomous mobility. Key risks include competitive pressures in ride-hailing, regulatory scrutiny, and execution challenges in new technology deployments that could impact growth and margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Uber Technologies Inc
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →
